PDCD1 and posterior cortical atrophy: Unfortunately, it was reported that some immune therapies targeting T-cell immune checkpoints, including CTLA-4, PD-L1 and PD-1, have not been demonstrated to be significantly efficient in PCa, which might be connected with the poor tumor immune microenvironment in PCa [8].